These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11523255)

  • 1. A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis.
    Hu Y; Tu S; Liu P
    J Tongji Med Univ; 2001; 21(1):72-4. PubMed ID: 11523255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M; Jakubicz D
    Rheumatol Int; 2007 May; 27(7):641-7. PubMed ID: 17235556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I
    Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone.
    Fiehn C; Jacki S; Heilig B; Lampe M; Wiesmüller G; Richter C; Röther E; Rochel E; Gao I
    Rheumatol Int; 2007 Aug; 27(10):975-9. PubMed ID: 17429636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate.
    Shin K; Baek HJ; Kang YM; Cha HS; Kang SW; Park SH; Jun JB; Lee YJ; Choi IA; Song YW
    Int J Rheum Dis; 2019 Jun; 22(6):1115-1122. PubMed ID: 30861334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
    Aletaha D; Stamm T; Kapral T; Eberl G; Grisar J; Machold KP; Smolen JS
    Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.
    De Stefano R; Frati E; Nargi F; Baldi C; Menza L; Hammoud M; Galeazzi M
    Clin Rheumatol; 2010 May; 29(5):517-24. PubMed ID: 20082236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K; Matsuno T
    Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis.
    Xiang N; Li XM; Zhang MJ; Zhao DB; Zhu P; Zuo XX; Yang M; Su Y; Li ZG; Chen Z; Li XP
    Int Immunopharmacol; 2015 Sep; 28(1):802-7. PubMed ID: 26292180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
    Huang RY; Pan HD; Wu JQ; Zhou H; Li ZG; Qiu P; Zhou YY; Chen XM; Xie ZX; Xiao Y; Huang QC; Liu L
    Phytomedicine; 2019 Apr; 57():403-410. PubMed ID: 30851515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
    Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide (Arava) is a useful DMARD in Indian (Asian) patients: a clinic-based observational study of 1-year treatment.
    Chopra A; Saluja M; Lagu-Joshi V; Sarmukadam S
    Clin Rheumatol; 2008 Aug; 27(8):1039-44. PubMed ID: 18470473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leflunomide in the treatment of rheumatoid arthritis].
    Kochbati S; Ben Miled M; Boussema F; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
    Tunis Med; 2005 Feb; 83(2):91-7. PubMed ID: 15969231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.